The “Liver Cancer Transplant & Oncology Congress”, to be held at Bahçeşehir University Beşiktaş South Campus B Conference Hall, will bring together leading experts in the field on March 27–28, 2026.
With the venue support provided by Bahçeşehir University and its Faculty of Medicine, the congress—taking place at the Beşiktaş South Campus—will address a wide range of current developments, from hepatocellular carcinoma and cholangiocarcinoma to metastatic liver tumors and transplantation processes.
On the first day of the congress, the focus will be on hepatocellular carcinoma (HCC). In addition to core topics such as diagnosis, classification, and risk stratification, discussions will include AI-assisted diagnostic methods, resectability criteria, and transplant decision-making processes. Advanced-stage disease management, including immunotherapy and combination treatment approaches, will also be evaluated in detail.
The second day will be dedicated to cholangiocarcinoma and metastatic liver cancers. Topics will include molecular classification, targeted therapies, neoadjuvant approaches, and the current role of transplantation. Innovative methods such as liquid biopsy and ctDNA in colorectal liver metastases will also be highlighted. Multidisciplinary panels and case presentations will provide valuable insights for clinical practice.
Through panels, satellite symposia, and interactive sessions within the scientific program, participants will have the opportunity to follow the latest advancements in liver cancer management.
The pre-registration process is ongoing for participation and detailed information. You can use the contact channels below to obtain information about the event organized by the congress and review the program schedule.
For pre-registration and detailed information:
Contact: Övgehan Gümüşhan
E-mail: [email protected]
Mobile: +90 539 938 75 35
TR
